Source: Almonty Industries
The Market Herald - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Almonty Industries (AII) receives conditional approval from the TSX to settle fees linked to debt obligations via shares
  • The approval comes at the request of Almontee investor Plansee Holding AG
  • Currently, Almonty owes Plansee US$2.4 million (A$3.6 million), which has now been settled through the issuance of 4,501,840 common shares on the TSX
  • Following the conversion of the outstanding fees, Plansee will hold 18.7 per cent of Almonty
  • AII Industries is down 4.76 per cent, trading at 70 cents at 2:42 pm AEDT

Almonty Industries (AII) has received conditional approval from the TSX to settle fees linked to debt obligations via shares.

The conditional approval to settle the fees in stock rather than cash came at the request of AII investor Plansee Holding AG.

Currently, Almonty owes Plansee US$2.4 million (A$3.6 million), which has now been settled through the issuance of 4,501,840 common shares on the TSX.

The average price of the stock issuance is 73 Canadian cents per share (80 Australian cents), which represents a six per cent premium to AII’s market price as of March 22, 2023.  

Following the conversion of the outstanding fees, Plansee will hold 18.7 per cent of Almonty.

Aside from a debt settlement agreement entered between Plansee and the company, Almonty said it did not anticipate entering any further agreements in connection with this transaction.

AII shares were down 4.76 per cent and trading at 70 cents at 2:42 pm AEDT.

AII by the numbers
More From The Market Herald

BBX Minerals extends Ema REE mineralisation to 7km x 6km

BBX Minerals (ASX:BBX) has extended the REE mineralisation at Ema in the Apuí region of Brazil…

TMH Market Update: ASX200 down 0.3pc as energy sector falters

The ASX200 is down just over a third of a per cent. Most sectors are in…

Cynata Therapeutics receives approval to launch phase two trial of CYP-001 in Turkey

Cell therapy company, Cynata Therapeutics (ASX:CYP) has received regulatory and ethics approval to commence a phase…

Elixir Energy announces unexpected gas-bearing zone discovery

Elixir Energy (ASX:EXR) has announced the unexpected discovery of a naturally permeable gas-bearing zone within its…